← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jun 1, 2009
Impact Therapeutics, Inc.— Founded
2010s
- Aug 16, 2019
fedratinib— Marketing Organization
- Aug 16, 2019
fedratinib— NDA Secondary Org
Drugs by trial phase (7 distinct, 20 trials)
Indications
Marketed drugs (1)
Recent trials (20)
- NCT06907043CollaboratorPhase 1/Phase 2Apr 30, 2025
- NCT07019194Lead sponsorPhase 1Jun 21, 2024
- NCT06253130CollaboratorPhase 1/Phase 2Dec 11, 2023
- NCT05919238Lead sponsorPhase 1Oct 30, 2023
- NCT05918783Lead sponsorPhase 1Oct 30, 2023
- NCT05390944Lead sponsorPhase 1Jun 8, 2022
- NCT05391048Lead sponsorPhase 1Jun 6, 2022
- NCT05269316Lead sponsorPhase 1Feb 11, 2022
- NCT04822961Lead sponsorPhase 2Oct 31, 2021
- NCT05109832Lead sponsorPhase 1Oct 30, 2021
- NCT07030439Lead sponsorPhase 1Jul 18, 2021
- NCT04768868Lead sponsorPhase 1Feb 25, 2021
- NCT04584515Lead sponsorPhase 1Nov 2, 2020
- NCT04434482Lead sponsorPhase 1Jun 30, 2020
- NCT04351165Lead sponsorPhase 1Apr 30, 2020
Details
- Founded
- Nanjing, CN Jun 1, 2009
- Last known activity
- Apr 30, 2025